.png){kind=icon}
返回
Ulcerative colitis
.png){kind=icon}
PRE
AI
DOI：10.1016/S0140-6736(12)60150-0.png)
.png){kind=icon}
原文求助.png){kind=icon}
分享.png){kind=icon}
收藏
摘要
En 中文
Ulcerative colitis is an idiopathic, chronic inflammatory disorder of the colonic mucosa, which starts in the rectum and generally extends proximally in a continuous manner through part of, or the entire, colon; however, some patients with proctitis or left-sided colitis might have a caecal patch of inflammation. Bloody diarrhoea is the characteristic symptom of the disease. The clinical course is unpredictable, marked by alternating periods of exacerbation and remission. In this Seminar we discuss the epidemiology, pathophysiology, diagnostic approach, natural history, medical and surgical management, and main disease-related complications of ulcerative colitis, and briefly outline novel treatment options. Enhanced understanding of how the interaction between environmental factors, genetics, and the immune system results in mucosal inflammation has increased knowledge of disease pathophysiology. We provide practical therapeutic algorithms that are easily applicable in daily clinical practice, emphasising present controversies in treatment management and novel therapies.
Keyword:
INFLAMMATORY-BOWEL-DISEASE
POUCH-ANAL ANASTOMOSIS
FACTOR-KAPPA-B
RANDOMIZED CONTROLLED-TRIAL
EVIDENCE-BASED CONSENSUS
NECROSIS-FACTOR-ALPHA
COLORECTAL-CANCER
CROHNS-DISEASE
RISK-FACTORS
DOUBLE-BLIND
AI总结
对已上传原文的论文进行重点信息的提取，主要内容包括：简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。
期刊
IF:
88.5
论文数:
5.4W
被引数:
34.8W
机构
引用论文
Metabotropic Glutamate Receptor Modulation of Glutamate Responses in the Suprachiasmatic Nucleus
PREAI
分享收藏
分享收藏Delayed-Release Oral Mesalamine 4.8 g/day (800-mg Tablet) Is Effective for Patients With Moderately Active Ulcerative Colitis.png)
GASTROENTEROLOGY
GASTROENTEROLOGYIF25.1
PREAI
分享收藏
查看更多内容